Content
All Posts > Content under
Weekly Forex Forecast - Sunday, Jan. 2
Article By:
Christopher Lewis
Read
Sunday, January 2, 2022 5:15 PM EDT
The euro initially fell during the previous week but then ended up closing at the very top of the range that we have been in. This is a little bit of a “heads up” about the thinking of traders as we step into the new year.
The Week Ahead In Biotech (Jan. 2-Jan. 8): Stray Clinical Readouts In Focus In Slow News Week
Johnson & Johnson: More Downside Is Expected Before Resuming The Rally
Article By:
Elliottwave Forecast
Read
Sunday, January 2, 2022 4:45 PM EDT
Since the crash of March 2020, all stocks have tried to recover what they lost, and Johnson & Johnson was no exception. Johnson & Johnson did not only recover the loss, but it also reached historic highs. Let's take a look.
In this article: JNJ
The Protected Wheel Options Strategy
Article By:
Gavin McMaster
Read
Sunday, January 2, 2022 4:30 PM EDT
The wheel options strategy is an excellent income-generating strategy that we have discussed before. However, it is not without risk. It has undefined risk in all phases of the wheel.
What Will Be The Tune Of Markets In 2022?
Article By:
Keith Schneider
Read
Sunday, January 2, 2022 4:00 PM EDT
When you have 3 good-to-great years, one must expect that at some point there will be a reversion to the mean. Market returns will inevitably fall back to long-term averages.
Tesla Q4 Deliveries Beat Consensus By A Mile, Pushing Annual Sales To Nearly 1M
Article By:
Benzinga
Read
Sunday, January 2, 2022 3:45 PM EDT
Tesla, Inc. reported record quarterly and annual deliveries that exceeded the most optimistic Wall Street forecasts. The strong performance came against the backdrop of supply-side constraints that derailed production plans of many automakers.
In this article: TSLA
The S&P 500 Trend Is Higher Until Proven Otherwise: Top Trade Q1 2022
Article By:
DailyFX
Read
Sunday, January 2, 2022 3:30 PM EDT
The S&P 500 has been trending higher ever since the pandemic low. That is difficult to bet against, even if it seems too high to buy. That doesn’t mean we should get complacent, as an extended market can turn on a dime and do-so with little warning.
In this article: SPX
2020-22: Soaring Costs Of The West's Pandemic Failure
Article By:
Dr. Dan Steinbock
Read
Sunday, January 2, 2022 3:15 PM EDT
The West failed to contain the pandemic, which has caused almost 300 million confirmed cases, 6 million deaths, and the loss of tens of trillions of dollars. For most the pandemic has been a nightmare. But it has been heaven for vaccine producers.
AT&T, Verizon Reject Biden Admin's Request To Delay 5G Launch Due To Flight Safety Concerns
Article By:
Tyler Durden
Read
Sunday, January 2, 2022 3:00 PM EDT
In a shocking turn of events in this age, AT&T and Verizon have rebuffed a request from federal transportation officials to delay the launch of new 5G wireless services.
New Years Resolutions To Be Financially Successful In 2022
Video By:
Casey T. Smith
Watch
Sunday, January 2, 2022 2:45 PM EDT
People often have New Years resolutions related to finance. In this brief video, I walk you through ways to be financially successful in 2022.
Top Retail Stocks: Trading Opportunities For Next Week
Article By:
Tickeron
Read
Sunday, January 2, 2022 2:30 PM EDT
A security pattern traces the distinct movements of prices, which helps traders make informed trading decisions. These patterns are identified by their vital geometrical elements. Let's look at some stock opportunities by analyzing these patterns.
From Whatever It Takes To Retiring Transitory – The End Of The Post-COVID-19 Bubble
Article By:
Greg Feirman
Read
Sunday, January 2, 2022 2:15 PM EDT
The Fed’s purchases of treasuries and mortgage backed securities have flooded the markets with cash, and much of that cash has found its way into stocks. As the Fed decreases its asset purchases, it’s inevitable that stock market gains will slow.
In this article: SPX
Fear & Greed In The Biotech Sector
Article By:
MoneyShow.com
Read
Sunday, January 2, 2022 1:45 PM EDT
With rates rising, widespread tax-loss selling, and fund manager’s either closing the books for 2021 or just closing down altogether, the market has entered a major risk off phase and biotech stocks are the ultimate whipping boy.
In this article: XBI